发明名称 CONTROLLED-RELEASE COMPOSITION CONTAINING OPIOID AGONIST AND ANTAGONIST
摘要 <P>PROBLEM TO BE SOLVED: To urge approval of a patient, and thereby to increase effects of opioid agonist treatment of a patient to be treated with the opioid agonist. <P>SOLUTION: Controlled-release dosage forms containing an opioid agonist; an opioid antagonist; and a controlled release material release during a dosing interval an analgesic or sub-analgesic amount of the opioid agonist along with an amount of the opioid antagonist effective to attenuate a side effect of the opioid agonist. The dosage form provides analgesia for at least about 8 hours when administered to human patients. In other embodiments, the dose of antagonist released during the dosing interval enhances the analgesic potency of the opioid agonist. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012176993(A) 申请公布日期 2012.09.13
申请号 JP20120138857 申请日期 2012.06.20
申请人 EURO-CELTIQUE SA 发明人 OSHLACK BENJAMIN;CURTIS WRIGHT
分类号 A61K9/08;A61K45/08;A61K9/00;A61K9/02;A61K9/14;A61K9/16;A61K9/20;A61K9/22;A61K9/26;A61K9/28;A61K9/48;A61K9/50;A61K9/52;A61K9/54;A61K9/58;A61K9/70;A61K31/135;A61K31/137;A61K31/451;A61K31/46;A61K31/485;A61K38/00;A61K45/06;A61K47/02;A61K47/04;A61K47/12;A61K47/14;A61K47/26;A61K47/32;A61K47/38;A61K47/46;A61P25/04;A61P39/00;A61P43/00 主分类号 A61K9/08
代理机构 代理人
主权项
地址
您可能感兴趣的专利